Low‐dose short‐term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post‐transplant hepatitis B virus prophylaxis?

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|17|3|329-333

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.17, Iss.3, 2015-06, pp. : 329-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-Term Lamivudine for the Treatment of Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 367-372

Karger

Access to resources Recommend Favorite

Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen–positive liver transplant recipients after longterm minimal immunosuppression

By  

LIVER TRANSPLANTATION, Vol. 22, Iss. 9, 2016-09 ,pp. : 1205-1213

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Hepatitis B virus quasispecies evolution after liver transplantation in patients under long‐term lamivudine prophylaxis with or without hepatitis B immune globulin

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 208-220

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short-Term Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 362-366

Karger

Access to resources Recommend Favorite